Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 5 of 5 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/30/04
End: 05/31/06
Due: 05/31/07
Phase: N/A
Priority: Normal
Start: 09/30/05
End: 09/30/07
Due: 09/30/08
Phase: N/A
Priority: Normal
Start: 04/30/05
End: 12/31/07
Due: 12/31/08
Phase: N/A
Priority: Normal
Start: 07/31/07
End: 12/31/10
Due: 12/31/11
Phase: N/A
Priority: Normal
Start: 04/30/05
End: 10/31/07
Due: 10/31/08
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Miltefosine for Mucosal Leishmaniasis | NCT00373776 | AB Foundation | user2@example.com | None | 2004-04-30 | 2006-05-31 | 2007-05-31 | - | - | 2025-07-14 |
| Miltefosine to Treat Cutaneous Leishmaniasis in Bolivia | NCT00233545 | AB Foundation | user2@example.com | None | 2005-09-30 | 2007-09-30 | 2008-09-30 | - | - | 2025-07-14 |
| Miltefosine (Long Course) for Bolivian Mucosal Leishmaniasis | NCT00373568 | AB Foundation | user2@example.com | None | 2005-04-30 | 2007-12-31 | 2008-12-31 | - | - | 2025-07-14 |
| Safety and Efficacy of Oral Miltefosine in Patients With Post Kala Azar Dermal Leishmaniasis (PKDL) | NCT01635777 | AB Foundation | user2@example.com | None | 2007-07-31 | 2010-12-31 | 2011-12-31 | - | - | 2025-07-14 |
| Miltefosine for Brazilian Visceral Leishmaniasis | NCT00378495 | AB Foundation | user2@example.com | None | 2005-04-30 | 2007-10-31 | 2008-10-31 | - | - | 2025-07-14 |